Company News For August 29, 2017

·         Shares of Expedia Inc. EXPE declined 4.5% after the company’s Chief Executive Officer Dara Khosrowshahi announced that he would be joining Uber as CEO

·         Biogen Inc.’s BIIB shares surged 2.5% following positive results from an Alzhiemer’s drug study

·         Shares of Gilead Sciences Inc.  GILD increased 1.2% after it entered into an agreement with Kite Pharma Inc. KITE to acquire the company for a whopping $11 billion in cash

·         Johnson & Johnson’s JNJ shares increased almost 0.1% after it announced favorable results in a phase 3 study of its blood-thinning drug Xarelto

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Expedia, Inc. (EXPE): Free Stock Analysis Report

Johnson & Johnson (JNJ): Free Stock Analysis Report

Gilead Sciences, Inc. (GILD): Free Stock Analysis Report

Biogen Inc. (BIIB): Free Stock Analysis Report

Kite Pharma, Inc. (KITE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research